A book entitled “Hyaluronic Acid for Biomedical and Pharmaceutical Applications” has recently been published by Smithers-Rapra, a world leading publisher in polymer science and technology, under the editorship of Dr. Maurice N. Collins (Stokes Institute, UL). Dr Collins explains “Hyaluronic acid is a biopolymer that offers unique characteristics as a biomaterial. It is biodegradable, biocompatible and bioactive. It has been used in therapeutic applications associated with ocular therapies and it allows the potential for controlled/tuneable properties as well as ease of hydrogel formation by chemical modification. It exhibits low non-specific adsorption of proteins allowing specific interactions with cells. HA-based materials are particularly useful as wound grafts to treat chronic wounds or wounds in patients with impaired healing such as diabetic patients”.
The book consists of a collection of invited chapters from leading researchers from Europe, the US and Asia. Some of the topics addressed include the role of hyaluronic acid in scaffolds for sustaining stem cells for neural and bone regrowth, tumour targeted drug delivery, pharmaceutical processing, reconstructive surgery and the future prospects for hyaluronic acid in therapeutics. The book will be of interest to materials scientists, biomedical and chemical engineers, chemists and medics.
Copies are available through Smithers-Rapra and Amazon.